Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses - Schedule of Accrued Expenses (Details)

v3.23.3
Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Accrued Liabilities, Current [Abstract]    
External research and preclinical development $ 11,643 $ 8,219
Employee compensation and benefits (Note 13) 7,941 8,529
Professional fees 1,300 1,164
Facilities and other 605 54
Accrued expenses $ 21,489 $ 17,966